SecSonar.com

Chemed Corporation (CHE)

Chemed Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Chemed Corporation (CHE) is a Medical - Care Facilities company based in US with a market capitalization of $5.8B. Revenue grew 4.1% year-over-year and the company generated $325.5M in free cash flow. This page tracks CHE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 15.7K employees · IPO May 3, 1973

Valuation

Valuation & price

$434.53 · as of May 17, 2026 · -11.3% vs 52w high

23.6

P/E ratio

Latest-FY diluted EPS

5.95

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$490$429$369Jul 25Dec 25Jul 26Jul 7, 25$460.70Jul 9, 25$471.57Jul 11, 25$459.91Jul 15, 25$453.72Jul 17, 25$457.46Jul 21, 25$449.42Jul 23, 25$466.11Jul 25, 25$470.72Jul 29, 25$464.69Jul 31, 25$412.30Aug 4, 25$423.33Aug 6, 25$428.91Aug 11, 25$432.14Aug 13, 25$450.36Aug 15, 25$445.11Aug 19, 25$453.85Aug 21, 25$454.09Aug 25, 25$456.00Aug 27, 25$455.33Aug 29, 25$457.95Sep 3, 25$459.63Sep 5, 25$465.63Sep 9, 25$462.75Sep 11, 25$457.89Sep 16, 25$447.63Sep 18, 25$458.25Sep 22, 25$455.91Sep 24, 25$456.98Sep 26, 25$462.23Sep 30, 25$447.74Oct 2, 25$442.04Oct 6, 25$435.38Oct 8, 25$434.96Oct 10, 25$430.02Oct 14, 25$437.13Oct 16, 25$430.92Oct 21, 25$441.00Oct 23, 25$435.39Oct 27, 25$436.78Oct 29, 25$465.54Oct 31, 25$431.30Nov 4, 25$439.09Nov 6, 25$430.59Nov 10, 25$435.99Nov 12, 25$447.55Nov 14, 25$435.56Nov 18, 25$435.33Nov 20, 25$429.33Nov 25, 25$440.70Nov 28, 25$439.19Dec 2, 25$429.54Dec 4, 25$424.30Dec 8, 25$412.50Dec 10, 25$425.44Dec 12, 25$430.06Dec 16, 25$429.13Dec 18, 25$430.24Dec 22, 25$435.74Dec 24, 25$435.28Dec 29, 25$434.43Jan 2, 26$423.79Jan 6, 26$441.09Jan 8, 26$449.18Jan 12, 26$446.15Jan 14, 26$451.82Jan 16, 26$451.90Jan 21, 26$453.53Jan 23, 26$446.77Jan 27, 26$436.72Jan 29, 26$430.00Feb 2, 26$435.27Feb 4, 26$443.76Feb 9, 26$448.17Feb 11, 26$462.89Feb 13, 26$473.22Feb 18, 26$467.65Feb 20, 26$475.41Feb 24, 26$468.32Feb 26, 26$396.63Mar 2, 26$421.40Mar 4, 26$410.99Mar 6, 26$407.88Mar 10, 26$400.76Mar 12, 26$399.55Mar 17, 26$399.34Mar 19, 26$384.83Mar 23, 26$373.42Mar 25, 26$374.02Mar 27, 26$368.59Mar 31, 26$377.74Apr 2, 26$380.60Apr 7, 26$388.95Apr 9, 26$390.85Apr 13, 26$387.62Apr 15, 26$377.61Apr 17, 26$384.61Apr 22, 26$373.15Apr 24, 26$421.11Apr 28, 26$421.10Apr 30, 26$424.98May 4, 26$425.92May 6, 26$424.56May 8, 26$424.26May 12, 26$419.65May 14, 26$426.21May 18, 26$441.62May 20, 26$441.61May 22, 26$439.36May 28, 26$439.89Jun 1, 26$422.84Jun 3, 26$426.86Jun 5, 26$441.59Jun 9, 26$446.26Jun 11, 26$420.87Jun 15, 26$423.49Jun 17, 26$436.03Jun 22, 26$436.07Jun 24, 26$447.29Jun 26, 26$463.28Jul 2, 26$489.66
$368.5952-week range$489.66
Loading valuation history…

Fundamentals

Key fundamentals

$5.8B

Market cap

4.1%

Revenue growth (YoY)

30.0%

Gross margin

$325.5M

Free cash flow (USD)

$80.2M

Net debt

-4.2%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.6BFY 2017$1.7BFY 2018$1.8BFY 2019$1.9BFY 2020$2.1BFY 2021$2.1BFY 2022$2.1BFY 2023$2.3BFY 2024$2.4BFY 2025$2.5B
$1.6B$2.5B

Free cash flow by year

2016 → 2025

FY 2016$95.6MFY 2017$98.2MFY 2018$234.3MFY 2019$248.2MFY 2020$430.5MFY 2021$249.9MFY 2022$252.6MFY 2023$273.4MFY 2024$368.0MFY 2025$325.5M
$95.6M$325.5M

Gross margin by year

2021 → 2025

FY 202136.0%FY 202235.8%FY 202335.3%FY 202435.1%FY 202530.0%
36.0%30.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

4

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 28, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $603KLINDELL ANDREA R · Director · $602.6KJun 10, 2026Filing
  • Insider sellInsider Sell $219KWALSH GEORGE J III · Director · $218.9KMay 29, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 19, 2026Filing
  • Insider sellInsider Sell $26KGRACE PATRICK P · Director · $25.5KMay 8, 2026Filing
  • Insider sellInsider Sell $842KMCNAMARA KEVIN J · Director, president and CEO · $842.3KMay 4, 2026Filing
  • Quarterly report10-Q FiledApr 28, 2026Filing
  • 8-K eventEarnings ReleaseApr 23, 2026Filing
  • 8-K eventCredit Facility AmendedApr 13, 2026Filing

Questions

Frequently asked questions

What is Chemed Corporation's market cap?

Chemed Corporation (CHE) has a market capitalization of $5.8B.

What is CHE's P/E ratio?

CHE trades at a price-to-earnings ratio of 23.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is CHE's price-to-book (P/B) ratio?

CHE trades at 5.95 times book value per share.

Are insiders buying CHE stock?

SEC Form 4 filings show no open-market insider buys at Chemed Corporation in the last 90 days (4 sells).

Same arena

Related companies in Medical - Care Facilities

OPCH

Option Care Health, Inc.

$3.3B

BKD

Brookdale Senior Living Inc.

$3.1B

LFST

LifeStance Health Group, Inc.

$3B

NHC

National HealthCare Corporation

$2.9B

UHS

Universal Health Services, Inc.

$9.3B

ACHC

Acadia Healthcare Company, Inc.

$2.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.